15 Questions for Optum’s Dr. Robert Hall

Why It Matters

Understanding these age‑specific risks helps employers and insurers curb claim costs while ensuring older workers receive safe, effective treatment that speeds their return to productivity.

Key Takeaways

• Muscle mass declines 3–8% per decade after age 30.
• NSAIDs risk fatal complications in older workers with comorbidities.
• PBMs can flag drug interactions, preventing kidney injury.
• Provider shortages extend recovery, hindering return-to-work.
• Modified duty accelerates functional recovery for aging claimants.

Pulse Analysis

The United States is witnessing a demographic shift in its labor force, with a growing share of workers over 55 facing workplace injuries. As muscle mass erodes by up to 8% each decade after age 30, recovery timelines lengthen and the risk of secondary complications rises. This physiological reality intersects with a high prevalence of chronic conditions—90% of adults over 65 carry at least one, many two or more—creating a perfect storm for polypharmacy and adverse drug events. For workers’ compensation stakeholders, the stakes are clear: mismanaged medication regimens can trigger kidney failure, cardiovascular crises, or prolonged disability, inflating claim costs and eroding employee morale.

Pharmacy benefit managers (PBMs) are uniquely positioned to act as the "quarterback" in this complex care ecosystem. By integrating real‑time prescription data with clinical decision support, PBMs can alert prescribers to dangerous drug‑drug interactions—such as NSAIDs combined with anticoagulants—or suggest safer alternatives for patients with renal impairment. This proactive oversight not only mitigates health risks but also reduces downstream expenses tied to dialysis, hospital readmissions, and extended time off work. Moreover, PBMs can facilitate coordinated care pathways that align medication choices with the functional goals of modified‑duty programs, ensuring that therapeutic decisions support, rather than hinder, a gradual return to productivity.

Beyond medication management, broader systemic challenges demand attention. A projected shortage of up to 80,000 primary‑care physicians will strain access to timely evaluations, especially for older claimants juggling multiple health issues. Delays in care exacerbate deconditioning, increase reliance on high‑cost specialty drugs, and amplify the impact of social determinants like financial hardship and food insecurity. Leveraging generative AI tools can help clinicians sift through the 1.5 million new medical articles published annually, distilling evidence‑based guidance while flagging potential misinformation. When combined with robust PBM analytics and employer‑driven modified‑duty strategies, these technologies can transform the workers’ compensation landscape, delivering safer, faster recoveries for an aging workforce.